We are live on
!
Find out more
CIC
Crawford Investment Counsel Portfolio holdings
AUM
$5.85B
1-Year Est. Return
12.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
+12.61%
3 Year Est. Return
+44.31%
5 Year Est. Return
+59.61%
10 Year Est. Return
+1,024.8%
AUM
$2.64B
AUM Growth
-$124M
(-4.5%)
Cap. Flow
-$59.6M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
28.04%
Holding
256
New
18
Increased
61
Reduced
123
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$51.6M |
| 2 |
Quest Diagnostics
DGX
|
+$48.4M |
| 3 |
Kinder Morgan
KMI
|
+$47.6M |
| 4 |
EOG Resources
EOG
|
+$39.3M |
| 5 |
GSK
GSK
|
+$9.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$64.6M |
| 2 |
Baxter International
BAX
|
+$54.1M |
| 3 |
Accenture
ACN
|
+$8.89M |
| 4 |
Aflac
AFL
|
+$7.3M |
| 5 |
Blackrock
BLK
|
+$7.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.5% |
| 2 | Energy | 13.9% |
| 3 | Industrials | 13.61% |
| 4 | Healthcare | 12.51% |
| 5 | Technology | 11.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
TotalEnergies
TTE
$196B
| $4.67M | 0.18% |
60,214,405,728
+4,298,133,091
| +8% | +$430K |
|
77
Pfizer
PFE
$151B
| $4.51M | 0.17% |
141,682
-1,387
| -1% | -$45.2K |
|
|
DNY
78
DELISTED
DONNELLEY R R & SONS CO
DNY
| $3.88M | 0.15% |
222,486
+21,310
| +11% | +$371K |
|
79
3M
MMM
$94.5B
| $3.85M | 0.15% |
29,801
-1,208
| -4% | -$162K |
|
80
IBM
IBM
$225B
| $3.53M | 0.13% |
22,714
-335
| -1% | -$53.8K |
|
81
General Mills
GIS
$20.1B
| $3.53M | 0.13% |
63,303
+40,053
| +172% | +$2.24M |
|
|
MDC
82
DELISTED
M.D.C. Holdings, Inc.
MDC
| $3.29M | 0.12% |
152,445
-20,291
| -12% | -$415K |
|
|
83
Eli Lilly
LLY
$1.09T
| $3.29M | 0.12% |
39,364
-847,955
| -96% | -$64.6M |
|
84
Boeing
BA
$185B
| $3.23M | 0.12% |
23,323
-600
| -3% | -$87.5K |
|
85
Equifax
EFX
$21.4B
| $3.22M | 0.12% |
33,191
| – | – |
|
|
VIVO
86
DELISTED
Meridian Bioscience Inc
VIVO
| $3.06M | 0.12% |
164,250
-93,970
| -36% | -$1.74M |
|
|
CMO
87
DELISTED
Capstead Mortgage Corp.
CMO
| $3.01M | 0.11% |
270,929
+43,107
| +19% | +$508K |
|
88
Allstate
ALL
$67.7B
| $2.75M | 0.1% |
42,430
| – | – |
|
|
ATRI
89
DELISTED
Atrion Corp
ATRI
| $2.49M | 0.09% |
6,355
-580
| -8% | -$207K |
|
90
Mesa Laboratories
MLAB
$592M
| $2.49M | 0.09% |
28,035
-2,600
| -8% | -$220K |
|
91
Woodward
WWD
$21B
| $2.43M | 0.09% |
44,190
+1,000
| +2% | +$51.3K |
|
92
Colgate-Palmolive
CL
$73.9B
| $2.4M | 0.09% |
36,706
| – | – |
|
93
Cracker Barrel
CBRL
$1.26B
| $2.24M | 0.08% |
15,010
+540
| +4% | +$76.9K |
|
|
CEB
94
DELISTED
CEB Inc.
CEB
| $2.21M | 0.08% |
25,399
-1,700
| -6% | -$145K |
|
95
World Kinect Corp
WKC
$1.91B
| $2.19M | 0.08% |
45,700
+6,800
| +17% | +$356K |
|
|
BMTC
96
DELISTED
Bryn Mawr Bank Corp
BMTC
| $2.17M | 0.08% |
72,018
+1,800
| +3% | +$54.3K |
|
|
CYT
97
DELISTED
CYTEC INDS INC
CYT
| $2.17M | 0.08% |
35,784
-4,300
| -11% | -$250K |
|
98
Kimberly-Clark
KMB
$35.9B
| $2.15M | 0.08% |
20,295
-633
| -3% | -$68.9K |
|
|
FDO
99
DELISTED
FAMILY DOLLAR STORES
FDO
| $2.14M | 0.08% |
27,141
-410
| -1% | -$32.3K |
|
100
Littelfuse
LFUS
$11.7B
| $2.1M | 0.08% |
22,110
+1,500
| +7% | +$146K |
|
Similar funds
LIP
BSL
SC
MWM
WAM
PP
CGPCS
AL
Crawford Investment Counsel's Q2 2015 Portfolio in Review
As of Q2 2015, Crawford Investment Counsel held 256 positions worth $2.64B, down 4.5% from $2.76B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Crawford Investment Counsel's Q2 2015 filing shows 18 new, 61 increased, 123 reduced and 12 closed positions. Its largest new stake was Kinder Morgan: 1,139,802 shares worth $43.8M. The largest sale was Eli Lilly, an estimated $64.6M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Energy and Industrials.
- Crawford Investment Counsel's largest Q2 2015 buy was Kinder Morgan: 1,139,802 shares worth $43.8M.
- Crawford Investment Counsel added most to Honeywell in Q2 2015, an estimated $51.6M increase.
- Crawford Investment Counsel's biggest Q2 2015 reduction was Eli Lilly, cutting an estimated $64.6M.
- Crawford Investment Counsel fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $2.88M.
- Crawford Investment Counsel's ten largest holdings make up 28% of its $2.64B portfolio in Q2 2015.
- Crawford Investment Counsel opened 18 new positions and closed 12 in Q2 2015.
- Crawford Investment Counsel's portfolio value fell 4.5% quarter-over-quarter to $2.64B.
Based on Crawford Investment Counsel's 13F filing for Q2 2015, filed 17 Jul 2015.